GC38066
Mavacoxib
Also known as 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
Mavacoxib is a selective, oral long-acting cyclooxygenase-2 (COX-2) inhibitor and a long-acting non-steroidal anti-inflammatory drug (NSAID)
ChemicalCAS170569-88-7MW385.34FormulaC16H11F4N3O2S
- CAS number
- 170569-88-7
- Molecular weight
- 385.34
- Formula
- C16H11F4N3O2S
- Solubility
- DMSO： 250 mg/mL (648·78 mM)
- InChIKey
- TTZNQDOUNXBMJV-UHFFFAOYSA-N
- Catalogue number
- GC38066
- Brand
- GLPBIO
Computed properties PubChem CID 9843089 · XLogP 3.1 · TPSA 86.4 Ų · H-bond donors 1
- XLogP
- 3.1
- TPSA
- 86.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 8
- Rotatable bonds
- 3
- Heavy atoms
- 26
SMILES C1=CC(=CC=C1C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F)F
Computed descriptors from PubChem (CID 9843089), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il